CME: Giant Cell Arteritis

Praxis (Bern 1994). 2021 Apr;110(6):285-292. doi: 10.1024/1661-8157/a003667.ABSTRACTCME: Giant Cell Arteritis Abstract. Giant cell arteritis (GCA) is the most common vasculitis among patients over the age of 50. Mainly large vessels are targeted. GCA can be differentiated into cranial and extra-cranial types; thus the symptoms can range from headache, blurred vision and jaw claudication to non-specific symptoms like fatigue, polymyalgia and fever. Complications such as an irreversible loss of vision are critical, which is why timeous diagnosis and treatment are essential. There are some recommendations for treatment, but no defined guidelines exist. Steroids have been the standard treatment for the past six decades and remain so, but side effects are common. Tocilizumab represents an alternative and more effective and safer treatment.PMID:33906446 | DOI:10.1024/1661-8157/a003667
Source: Praxis - Category: General Medicine Authors: Source Type: research